Oncology Firm Erasca Eyes US$300 Million IPO
Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market today under the symbol “ERAS”.
Read more
Erasca
the deep dive
Providing stock analysis for investors of the Canadian junior markets